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Abstract 1 
The purpose of the present study was to evaluate the anatomical relationship between 2 
the tumor, portal veins, hepatic arteries, and hilar hepatic ducts at the hepatic hilum 3 
using a novel preoperative fusion analysis for patients with hilar cholangiocarcinoma. 4 
This involved combining 3-dimensional multidetector-row computed tomography 5 
(3D-MDCT) with 3-D magnetic resonance imaging (MRI). This novel fusion imaging 6 
technique can play an important clinical role for patients undergoing surgery for hilar 7 
cholangiocarcinoma. 8 
 9 
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1. Introduction 1 
To determine the optimal surgical procedure for patients with hilar 2 
cholangiocarcinoma, it is essential to know the anatomical relationship between the 3 
tumor and the vessels around the hepatic hilum in individual patients. Several 4 
institutions have recently developed 3-dimensional multidetector-row computed 5 
tomography (3D-MDCT) cholangiography or drip infusion 3D-MDCT for use with 6 
patients with hilar cholangiocarcinoma [1-4]. However, it has been said that these 7 
radiological examinations have several problems with side effects such as cholangitis or 8 
anaphylactic shock due to infusion of the contrast material into the vein or bile duct. 9 
Therefore, we were looking forward to a new modality and method. To our knowledge 10 
there have been no published reports concerning the preoperative visualization of 11 
3D-MDCT fusion images combined with 3D-magnetic resonance 12 
cholangiopancreatography (MRCP) images. The purpose of the present study was to 13 
preoperatively evaluate portal veins and hilar hepatic ducts at the hepatic hilum in 14 
patients with hilar cholangiocarcinoma. 15 
 16 
2. Case 17 
The patient was a 52-year-old man. He consulted the Tsukuba University Hospital 18 
complaining of jaundice. Laboratory blood samples showed elevated total bilirubin and 19 
carcinogenic antigen (CA) 19-9, and MDCT and MRI were subsequently performed 20 
(Fig. 1). 21 
MDCT images were acquired using an IDT-16 imager (Philips, Eindhoven, The 22 
Netherlands). Scan settings included a pitch of 17, a 0.75-second scan time per rotation, 23 
a table speed of 12 mm/rotation, and a detector configuration of 0.75×16 mm. A power 24 
injector was used to administer 100 mL iopamidol (370 mgI/mL) at 4 mL/s through a 25 
20-G high pressure intravenous catheter. The MDCT protocol obtained 3 sets of hepatic 26 
images in succession, including images of arterial, and those of portal venous, and 27 
hepatic venous phases. The arterial phase images were obtained 5 seconds after peak 28 
aortic enhancement, portal venous phase images were taken 70 seconds after starting the 29 
injection, and the hepatic venous phase began 180 seconds after starting the injection. 30 
The MRI was performed on a 1.5 Tesla MRI imager (Achieva Nova Dual, Philips 31 
Medical Systems, Eindhoven, The Netherlands) 32 
The preoperative fusion examination consisted of 4 steps. We first combined heavily 33 
T2-weighted MRCP images with axial thin slice 3D-T1-turbo field echo (TFE) images. 34 
Second, we combined the thin TFE images with thin MDCT axial images. Third, we 35 
superimposed MRCP data onto the axial CT images, focusing on the area around the 36 
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hepatic hilum. Forth, we checked the following three registration landmarks: 1) the right 1 
border along the umbilical potion, 2) the bifurcation of the right and left hepatic arteries, 2 
and 3) the bifurcation of the right and left portal veins. Although we were able to 3 
delineate the hilar cholangiocarcinoma on the reconstructed 3D image by tracing the 4 
enhanced tumor on the 2D MDCT, we were not able to detect the tumor on the MRCP 5 
as expected. However, we confirmed that the resultant 3D fusion image was correct by 6 
checking the three registration landmarks (Fig. 2).  7 
We used the Synapse Vincent medical imaging system (Fujifilm Medical, Tokyo), 8 
which was developed specifically for 3D visualization and virtual resection of the liver. 9 
This software offers standardized computation of liver anatomy functions and 10 
volumetric risk analysis based on 2D-CT imaging. The structures of the liver, portal 11 
vein, hepatic artery, hepatic vein, and tumor were extracted from MDCT scan data. One 12 
of the most important points of this novel fusion imaging is to examine MDCT during 13 
the patient’s expiratory phase, which is the same condition of MRI. The user can 14 
visualize 3D images of the structures mentioned above as well as those of the hepatic 15 
arterial, portal, and hepatic venous phases. These images can also be rotated separately 16 
or simultaneously (Fig. 2). 17 
We diagnosed the patient’s disease as locally advanced hilar cholangiocarcinoma, T2, 18 
N1, M0, Stage IIB according to the UICC-TNM classification [5], and Type IIIb based 19 
on the Bithmuth- Corlette classification [6]. The patient and his family agreed to this 20 
procedure and provided informed consent. The patient tolerated MDCT and MRI 21 
without serious complications such as skin rash or other allergic adverse effects.  22 
A chief surgeon (R.S.) performed the surgical resection. Based on preoperative 23 
imaging, we determined that the most appropriate surgical procedure was left hepatic 24 
lobectomy combined with total caudate lobectomy and extrahepatic bile duct resection 25 
(Fig. 3), No concomitant vascular resection was performed. Operative time was 581 26 
minutes, and estimated blood loss was 1215 ml. The patient’s postoperative course was 27 
stable and uneventful, and he was discharged on postoperative day 14. Postoperative 28 
clinical pathology revealed that there was no residual carcinoma (R0). The patient is 29 
now alive 1 year and 1 month after surgery with no evidence of recurrence.  30 
  31 
Discussion 32 
To determine the optimal surgical approach to hilar cholangiocarcinoma for 33 
individual patients, it is essential to perform a detailed evaluation of the anatomical 34 
structures at the hepatic hilum. By using newly developed software and a novel method, 35 
we were able to easily analyze the hepatic arteries, portal veins, hepatic veins, and hilar 36 
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bile ducts without performing 3D-MDCT cholangiography or drip infusion 3D-MDCT. 1 
A more recent advance is the development of image integration, which refers to the 2 
process of registering previously acquired MRI and CT scans of the heart with the 3 
mapping space during an ablation procedure [7]. Further, a urology study has reported 4 
the usefulness of CT-MRI fusion imaging in radiotherapy planning for localized prostate 5 
cancer [8]. 6 
Several limitations of this novel modality should be addressed. First, at present this 7 
approach requires a considerable amount of time (about 5−6 hours) to create detailed 8 
images. Second, as described in the Patients and Methods section, obtaining images 9 
during the experiratory phase is one of the most important aspects of this method. 10 
Obtaining satisfactory images will be easiest with patients who are able to cooperate in 11 
this aspect. Third, this study involved only one patient, and our results will therefore 12 
need to be confirmed with larger populations.  13 
In conclusion, this novel fusion imaging technique should play an important role in 14 
preoperative planning for patients undergoing surgery for hilar cholangiocarcinoma.  15 
 16 
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Figure legends 1 
 2 
Fig. 1 Axial MDCT and MRCP. (A) Axial MDCT demonstrates bilateral intrahepatic 3 
bile duct dilatation. (B) MRCP demonstrates that the bilateral intrahepatic bile ducts 4 
were dilated, and that the confluence of the right and left hepatic ducts is tapered and 5 
obstructed at the hepatic hilum. 6 
 7 
Fig. 2 Preoperative fusion analysis using 3D-MDCT combined with 3D MRI imaging 8 
(A) and a virtual dissection line when performing left hepatic lobectomy (B). The red 9 
line indicates the planned dissection line. Novel modality was successfully described 10 
and the surgeon and surgical staff could determine the appropriate dissection line 11 
preoperatively.  12 
 13 
Fig. 3 The actual liver cut surface shows the stump of the left hepatic vein, the middle 14 
hepatic vein, and an orifice of the right hepatic duct. This ductal margin was confirmed 15 
as histologically negative. The relationship between the right hepatic duct and right 16 
portal vein was the same as anticipated preoperatively. 17 
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